PMID- 22653339 OWN - NLM STAT- MEDLINE DCOM- 20130304 LR - 20211021 IS - 1476-5403 (Electronic) IS - 1350-9047 (Print) IS - 1350-9047 (Linking) VI - 19 IP - 11 DP - 2012 Nov TI - C/EBP homologous protein contributes to cytokine-induced pro-inflammatory responses and apoptosis in beta-cells. PG - 1836-46 LID - 10.1038/cdd.2012.67 [doi] AB - Induction of the C/EBP homologous protein (CHOP) is considered a key event for endoplasmic reticulum (ER) stress-mediated apoptosis. Type 1 diabetes (T1D) is characterized by an autoimmune destruction of the pancreatic beta-cells. Pro-inflammatory cytokines are early mediators of beta-cell death in T1D. Cytokines induce ER stress and CHOP overexpression in beta-cells, but the role for CHOP overexpression in cytokine-induced beta-cell apoptosis remains controversial. We presently observed that CHOP knockdown (KD) prevents cytokine-mediated degradation of the anti-apoptotic proteins B-cell lymphoma 2 (Bcl-2) and myeloid cell leukemia sequence 1 (Mcl-1), thereby decreasing the cleavage of executioner caspases 9 and 3, and apoptosis. Nuclear factor-kappaB (NF-kappaB) is a crucial transcription factor regulating beta-cell apoptosis and inflammation. CHOP KD resulted in reduced cytokine-induced NF-kappaB activity and expression of key NF-kappaB target genes involved in apoptosis and inflammation, including iNOS, FAS, IRF-7, IL-15, CCL5 and CXCL10. This was due to decreased IkappaB degradation and p65 translocation to the nucleus. The present data suggest that CHOP has a dual role in promoting beta-cell death: (1) CHOP directly contributes to cytokine-induced beta-cell apoptosis by promoting cytokine-induced mitochondrial pathways of apoptosis; and (2) by supporting the NF-kappaB activation and subsequent cytokine/chemokine expression, CHOP may contribute to apoptosis and the chemo attraction of mononuclear cells to the islets during insulitis. FAU - Allagnat, F AU - Allagnat F AD - Laboratoire de Medecine Experimentale, Universite Libre de Bruxelles, Brussels, Belgium. FAU - Fukaya, M AU - Fukaya M FAU - Nogueira, T C AU - Nogueira TC FAU - Delaroche, D AU - Delaroche D FAU - Welsh, N AU - Welsh N FAU - Marselli, L AU - Marselli L FAU - Marchetti, P AU - Marchetti P FAU - Haefliger, J A AU - Haefliger JA FAU - Eizirik, D L AU - Eizirik DL FAU - Cardozo, A K AU - Cardozo AK LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120601 PL - England TA - Cell Death Differ JT - Cell death and differentiation JID - 9437445 RN - 0 (Cytokines) RN - 0 (Interleukin-1beta) RN - 0 (Mcl1 protein, rat) RN - 0 (Myeloid Cell Leukemia Sequence 1 Protein) RN - 0 (NF-kappa B) RN - 0 (Proto-Oncogene Proteins c-bcl-2) RN - 0 (Transcription Factor RelA) RN - 0 (Tumor Necrosis Factor-alpha) RN - 147336-12-7 (Transcription Factor CHOP) RN - 82115-62-6 (Interferon-gamma) RN - EC 2.7.11.10 (I-kappa B Kinase) RN - EC 3.4.22.- (Caspase 3) RN - EC 3.4.22.- (Caspase 9) SB - IM MH - Animals MH - Apoptosis/*drug effects MH - Caspase 3/metabolism MH - Caspase 9/metabolism MH - Cell Line MH - Cell Nucleus/metabolism MH - Cytokines/*pharmacology MH - Diabetes Mellitus, Type 1/metabolism/pathology MH - Endoplasmic Reticulum Stress MH - I-kappa B Kinase/metabolism MH - Insulin-Secreting Cells/cytology/*metabolism MH - Interferon-gamma/pharmacology MH - Interleukin-1beta/pharmacology MH - Mitochondria/metabolism MH - Myeloid Cell Leukemia Sequence 1 Protein MH - NF-kappa B/metabolism MH - Proto-Oncogene Proteins c-bcl-2/metabolism MH - Rats MH - Transcription Factor CHOP/antagonists & inhibitors/genetics/*metabolism MH - Transcription Factor RelA/metabolism MH - Tumor Necrosis Factor-alpha/pharmacology PMC - PMC3469067 EDAT- 2012/06/02 06:00 MHDA- 2013/03/05 06:00 PMCR- 2013/11/01 CRDT- 2012/06/02 06:00 PHST- 2012/06/02 06:00 [entrez] PHST- 2012/06/02 06:00 [pubmed] PHST- 2013/03/05 06:00 [medline] PHST- 2013/11/01 00:00 [pmc-release] AID - cdd201267 [pii] AID - 10.1038/cdd.2012.67 [doi] PST - ppublish SO - Cell Death Differ. 2012 Nov;19(11):1836-46. doi: 10.1038/cdd.2012.67. Epub 2012 Jun 1.